Diabetes study probes Cholesterol's hidden effects on blood

NCT ID NCT05641753

Recruiting now Knowledge-focused Sponsor: NYU Langone Health Source: ClinicalTrials.gov ↗

First seen Jan 04, 2026 · Last updated Apr 24, 2026 · Updated 18 times

Summary

This study looks at how reducing cholesterol changes blood cell activity and blood vessel function in 125 people with type 1 diabetes. Participants will have their cholesterol lowered and be monitored for one to two months. The goal is to learn more about heart disease risks in diabetes, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Mount Sinai School of Medicine
RECRUITING

New York, New York, 10029, United States

Contact
NYC Health + Hospitals/Bellevue
RECRUITING

New York, New York, 10016, United States
NYU Langone Health
RECRUITING

New York, New York, 10016, United States
New York VA Hospital
RECRUITING

New York, New York, 10010, United States

Conditions

Explore the condition pages connected to this study.

TYPE 1 DIABETES